10.1007/s00726-017-2436-z 23 ChoiB.-H.ColoffJ
As GLP-1 analogs, GLP-1RAs effectively regulate blood glucose by inhibiting glucagon secretion, slowing gastric emptying, enhancing insulin sensitivity, and stimulating insulin secretion [51]
Whilst Wegovy does not typically cause these effects directly, the combination could potentially amplify cardiovascular strain, particularly in patients with pre-existing hypertension, coronary artery disease, or arrhythmias
Aside from semaglutide and tirzepatide, other notable GLP-1 agonists are dulaglutide, liraglutide, and exenatide
HCS-Pharma reviews extensive customer feedback, industry discussions, and long-term performance indicators to assess each companys reliability